Global /India /Healthcare /Drug Manufacturers - General /KREBSBIO
chevron_leftBack
Krebs Biochemicals & Industries Ltd. logo

Krebs Biochemicals & Industries Ltd.

KREBSBIO
NSE: KREBSBIO Delayed
59.67INR -0.6%
0.6320 USD
As of 22 June 2026, Krebs Biochemicals & Industries Ltd. has a market cap of $13.06M USD, ranking #39825 globally and #3039 in India. It ranks #3558 in the Healthcare sector, and #1161 in the Drug Manufacturers - General industry.
Global Rank
39825
Country Rank
3039
Sector Rank
3558
Industry Rank
1161
Key Stats
Market Cap
$13.06MUSD
1.23B INR
Enterprise Value
$36.52MUSD
3.45B INR
Revenue (TTM)
$2.44MUSD
230.23M INR
EBITDA (TTM)
-$1.05MUSD
-98.9M INR
Net Income (TTM)
-$2.42MUSD
-228.62M INR
EBITDA Margin
-43%
Profit Margin
-99%
PS Ratio
5.4
PB Ratio
-0.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Manish Jain open_in_new
Employees
202
Founded
1991
Website
krebsbiochem.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.6% -2.4% 37% 2.6% -15% -24%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
KREBSBIO
Krebs Biochemicals & Industries Ltd
ISIN: INE268B01013
Shares Out.:
21.561M1
TV:
SA:
YF:
GF:
BA:
MS:
59.67 INR
Bombay Stock Exchange
MIC: XBOM
524518 (KREBSBIO)
Krebs Biochemicals & Industries Ltd
ISIN: INE268B01013
TV:
SA:
YF:
GF:
BA:
MS:
57.26 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Krebs Biochemicals & Industries Ltd.

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is based in Visakhapatnam, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.15B
4.27T INR
346K%
39.1
DIVISLAB
$18.35B
1.73T INR
140K%
70.0
$15.15B
1.43T INR
116K%
63.0
$11.72B
1.11T INR
90K%
19.6
MANKIND
$9.86B
931.67B INR
75K%
52.2
ZYDUSLIFE
$9.7B
916.53B INR
74K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
6M%
38.1
JNJ
$547.28B
4M%
26.4
ABBV
$360.63B
3M%
97.4
$318.49B
256.25B CHF
2M%
19.9
AZN
$286.12B
215.59B GBP
2M%
27.6
MRK
$274.03B
2M%
15.1
chevron_leftBack